ACCELERON PHARMA INC. Cash and Restricted Cash
ACCELERON PHARMA INC. had Cash and Restricted Cash of $337.85 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-11-04
- 2021-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $337.85M.
- 2021-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $337.80M.
- 2021-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $457.11M.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $672.55M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2021-09-30 | $337.85M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $337.80M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $457.11M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $672.55M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $731.28M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $285.12M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $279.08M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $239.27M 10-Q · filed 2021-11-04 |
| 2019-09-30 | $171.14M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $165.21M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $216.09M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $145.65M 10-K · filed 2021-02-25 |
| 2018-09-30 | $114.02M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $80.72M 10-Q · filed 2019-08-05 |
| 2018-03-31 | $70.87M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $101.28M 10-K · filed 2021-02-25 |
| 2017-09-30 | $240.09M 10-Q · filed 2018-10-30 |
| 2017-06-30 | $31.86M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $34.29M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $21.90M 10-K · filed 2020-02-27 |
| 2015-12-31 | $28.58M 10-K · filed 2019-02-27 |